PARTIAL AGONIST PROPERTIES OF RAUWOLSCINE AND YOHIMBINE FOR THE INHIBITION OF ADENYLYL-CYCLASE BY RECOMBINANT HUMAN 5-HT(1A)-RECEPTORS

被引:27
作者
ARTHUR, JM
CASANAS, SJ
RAYMOND, JR
机构
[1] DUKE UNIV,MED CTR,DEPT MED,DIV NEPHROL,BOX 3459,DURHAM,NC 27710
[2] DEPT VET AFFAIRS MED CTR,MED SERV,NEPHROL SECT,DURHAM,NC 27705
[3] DUKE UNIV,MED CTR,DEPT MED,DIV CARDIOL,DURHAM,NC 27710
关键词
D O I
10.1016/0006-2952(93)90208-E
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previous studies by another group have suggested that the alpha2-adrenergic receptor antagonist rauwolscine may function as an agonist at the serotonin1A (5-HT1A) receptor expressed in human brain. To directly test that hypothesis, we transfected the human 5-HT1A receptor cDNA into CHO cells and examined the ability of rauwolscine and its isomer, yohimbine, to inhibit ligand binding of [H-3]-(+/-)-8-hydroxy-2-(di-n-propylamino)tetralin ([H-3]8-OH-DPAT) and the activity of adenylyl cyclase in membranes derived from a single transformant that stably expresses almost-equal-to 225 fmol of 5-HT1A receptor/mg of membrane protein. Both ligands competitively antagonized the binding of [H-3]8-OH-DPAT (K(i) = 158 +/- 69 nM for rauwolscine and 690 +/- 223 nM for yohimbine), yielding shallow displacement curves consistent with agonist activity (Hill values = 0.69 +/- 0.2 for rauwolscine and 0.63 +/- 0.06 for yohimbine). Both ligands also inhibited forskolin-stimulated adenylyl cyclase activity in membranes derived from transfected (but not nontransfected) cells. For rauwolscine, the IC50 was 1.5 +/- 0.2 muM, and for yohimbine 4.6 +/- 1.0 muM, with activity ratios of 0.70 and 0.59, respectively, when compared to the full agonist serotonin. These studies demonstrated that rauwolscine and yohimbine are partial agonists for the human 5-HT1A receptor.
引用
收藏
页码:2337 / 2341
页数:5
相关论文
共 36 条
  • [1] ALBERT PR, 1990, J BIOL CHEM, V265, P5825
  • [2] BODDEKE HWGM, 1992, N-S ARCH PHARMACOL, V345, P257
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] HETEROGENEOUS H-3 RAUWOLSCINE BINDING-SITES IN RAT CORTEX - 2 ALPHA-2-ADRENOCEPTOR SUBTYPES OR AN ADDITIONAL NON-ADRENERGIC INTERACTION
    BROADHURST, AM
    ALEXANDER, BS
    WOOD, MD
    [J]. LIFE SCIENCES, 1988, 43 (01) : 83 - 92
  • [5] CHONG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [6] CONNER DA, 1990, MOL PHARMACOL, V37, P742
  • [7] HIGH-AFFINITY BINDING OF H-3 RAUWOLSCINE AND H-3 RX781094 TO ALPHA-2 ADRENERGIC-RECEPTORS AND NON-STEREOSELECTIVE SITES IN HUMAN AND RABBIT BRAIN CORTEX MEMBRANES
    CONVENTS, A
    CONVENTS, D
    DEBACKER, JP
    DEKEYSER, J
    VAUQUELIN, G
    [J]. BIOCHEMICAL PHARMACOLOGY, 1989, 38 (03) : 455 - 463
  • [8] [H-3] RAUWOLSCINE LABELS ALPHA-2-ADRENOCEPTORS AND 5-HT1A RECEPTORS IN HUMAN CEREBRAL-CORTEX
    CONVENTS, A
    DEKEYSER, J
    DEBACKER, JP
    VAUQUELIN, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 159 (03) : 307 - 310
  • [9] Cornfield L J, 1988, Proc West Pharmacol Soc, V31, P265
  • [10] (H-3) RAUWOLSCINE BEHAVES AS AN AGONIST FOR THE 5-HT1A RECEPTORS IN HUMAN FRONTAL-CORTEX MEMBRANES
    DEVOS, H
    CZERWIEC, E
    DEBACKER, JP
    DEPOTTER, W
    VAUQUELIN, G
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1991, 207 (01): : 1 - 8